Cargando…
Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer
Worldwide, cancer is the second leading cause of mortality after cardiovascular diseases. Among the numerous malignant tumors in human, digestive system cancers are the primary cause of morbidity and mortality. Acetylation and deacetylation are crucially involved in cancer occurrence and development...
Autores principales: | Zhou, Bingyi, Liu, Deliang, Tan, Yuyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687743/ https://www.ncbi.nlm.nih.gov/pubmed/34938729 http://dx.doi.org/10.3389/fcell.2021.719390 |
Ejemplares similares
-
Recent Update of HDAC Inhibitors in Lymphoma
por: Chen, I-Chung, et al.
Publicado: (2020) -
The Role of HDAC6 in TDP-43-Induced Neurotoxicity and UPS Impairment
por: Lee, Shinrye, et al.
Publicado: (2020) -
HDAC Inhibitor Titration of Transcription and Axolotl Tail Regeneration
por: Voss, S. Randal, et al.
Publicado: (2021) -
The Role of HDACs and HDACi in Cartilage and Osteoarthritis
por: Zhang, He, et al.
Publicado: (2020) -
HDAC6 Interacts With Poly (GA) and Modulates its Accumulation in c9FTD/ALS
por: del Rosso, Giulia, et al.
Publicado: (2022)